Every one of these companies will tell you a licensed physician is running the show. That is the pitch, more or less word for word, on all six homepages. So I stopped reading the marketing copy and started asking a duller question: what would actually be true if that sentence were a lie, and does the record rule that out?

Here is the uncomfortable starting point. A questionnaire can be built to spit out a prescription-shaped result without a clinician ever really weighing your history. It can look, on a screen, identical to a doctor actually deciding your hormone, your dose, and your form. For most medications that gap is annoying. For estradiol it is the whole ballgame, because the wrong form isn’t just less effective, it can carry a different risk profile entirely.

So I built a checklist. Eight plain questions, the kind you’d actually ask a friend who’s been through this rather than recite from a clinical handout. Then I checked six real, operating menopause and hormone-therapy services against it: FormBlends, Midi Health, Evernow, Hone Health, Winona, and Alloy. Nobody on this list is a scam. That’s not the finding. The finding is that “a doctor is involved” turns out to be a much lower bar than “a doctor is doing the job thoroughly,” and most of these companies clear the first bar easily and the second one unevenly.

The one thing everybody passes, which tells you almost nothing

Start with the boring bar, because it matters that it’s boring: is the medication actually dispensed through a licensed pharmacy that follows quality standards? All six clear it. FormBlends works through a licensed compounding pharmacy. Midi, Evernow, and Alloy use standard or mail-order pharmacies. Winona works with compounding pharmacy partners, Hone Health with licensed pharmacies of its own. None of these six is shipping you a vial from a “research chemicals” site that screened you for nothing and answers to nobody.

That’s table stakes, not a differentiator. It’s also, frankly, the fact most gray-market vendors would love you to conflate with real oversight, since the molecule can be nominally identical while the accountability behind it is not. Once you clear that bar, the real question starts: who is actually choosing your hormone, dose, and form, and who’s still there when that needs to change?

See also: New Health Craze Promises to Revolutionize Fitness Industry

Where the sameness stops

Point one is the foundation question: does a licensed clinician actually pick the hormone, the dose, and the form, or does a symptom quiz do the deciding? This matters for estradiol specifically because the form is half the decision. Oral tablets and transdermal patches treat whole-body symptoms like hot flashes. Low-dose vaginal estradiol targets dryness and painful intercourse with very little hormone reaching the bloodstream [4]. Someone has to match the route to the woman, and that someone is supposed to be a person with a license, not an algorithm.

FormBlends has a licensed physician reviewing the profile and choosing the approach, and it’s built so the match can actually happen because it carries oral, transdermal, and vaginal estradiol. Midi Health scores well too, with menopause-trained clinicians choosing from FDA-approved forms. Alloy and Evernow both put real prescribers in charge. Hone Health and Winona involve clinicians as well, though I’d push on this in the actual consult: how much is the prescriber tailoring the pick to you, versus working off a tighter default menu?

The progestogen question nobody wants to be asked

Here’s the part of the record that gets glossed over the fastest, so let’s dwell on it. A provider can only match the form to the woman if it stocks more than one form, and it can only protect a woman with a uterus if it stocks the progestogen too. That second part is not a nice-to-have.

If you still have a uterus, estrogen taken alone stimulates the uterine lining and raises the risk of endometrial cancer, which is why a progestogen gets added. If you’ve had a hysterectomy, estradiol alone is usually fine. That single anatomical fact is also why the estrogen-alone arm of the Women’s Health Initiative told a different risk story than the combined arm [2][3]. A provider that can’t offer the progestogen, or doesn’t even ask whether you have a uterus, is missing a piece of the job that isn’t optional.

FormBlends carries the full kit here, oral, transdermal, and vaginal estradiol plus the progestogen. Midi and Alloy offer FDA-approved estradiol across forms with progesterone. Evernow covers oral and patch estradiol plus progesterone, a solid but slightly narrower menu. Winona offers multiple compounded forms. Hone Health leans toward broader hormone optimization, so I’d ask directly what its specific estradiol menu looks like for menopause.

Does the doctor stick around, or is this a one-and-done?

The awkward truth about “physician-supervised” is that supervision is a verb, not a one-time event at signup. The Endocrine Society guideline frames menopause therapy around the lowest effective dose for the appropriate duration, periodically reassessed [1]. Periodic reassessment only happens if the same provider is still paying attention months later. A prescription mailed out into the void isn’t oversight, it’s a transaction with extra paperwork.

FormBlends is built around ongoing adjustment rather than a plan fixed at signup, and it gives women a way to log symptoms and doses between visits (more on that below). Midi and Evernow, as ongoing menopause services, are built for continuing care. Alloy folds prescriber access into its membership. Hone Health runs on ongoing monitoring with labs. Winona’s model is more streamlined, which is fine, but it’s worth asking how the follow-up cadence actually works so you’re not the one solely tracking your own changes.

The “bioidentical” sales pitch that isn’t quite honest

This is where the marketing gets slippery, so it earns its own section. FDA-approved estradiol has been through formal review for safety, effectiveness, and quality, and it is itself bioidentical, meaning the molecule matches what your body makes. Compounded estradiol has not been through that review, which is a genuine caveat, though compounding has a legitimate role when an approved product simply doesn’t offer the form or dose someone needs. The honest version of this business reaches for an approved product where it fits, says so out loud, uses compounding under real supervision when there’s a genuine reason, and does not sell compounded “bioidenticals” as inherently safer or more natural, because the evidence doesn’t back that claim up.

Alloy and Midi lean toward FDA-approved products, a clean signal. FormBlends works through a compounding pharmacy and states the compounded-medication caveat plainly while noting an approved product is the right call where it fits, which is about as honest as a compounded model gets. Winona is primarily compounded, so if you’d prefer approved, that’s a conversation to have upfront. Evernow and Hone Health have clinicians who can walk you through the choice; just make sure you actually have that conversation rather than assuming it happened.

The fountain-of-youth tell

A provider with a real doctor behind it will tell you the plain truth about the drug: estradiol genuinely works for menopausal symptoms and is not a cure-all. The guideline calls menopausal hormone therapy the most effective treatment for vasomotor symptoms, with benefits that can outweigh risks for most symptomatic women under sixty or within ten years of menopause, individualized and screened first [P1]. It also says, without hedging, that hormone therapy should not be used to prevent heart disease, dementia, or other chronic disease [P1]. Any provider promising you it’ll protect your heart or roll back the clock has told you something about its priorities, and it isn’t accuracy.

FormBlends, Midi, Alloy, and Evernow all frame estradiol as symptom treatment with a real, bounded benefit window and specific risks, not anti-aging. If you ever see the fountain-of-youth version of this pitch anywhere, that’s a reason to look harder, not a reason to buy.

The numbers the trial actually produced

This is the part where the record stops being abstract. The Women’s Health Initiative’s estrogen-plus-progestin arm, in 16,608 women with a uterus, was stopped early because overall risks exceeded benefits, with increased breast cancer, coronary heart disease, stroke, and pulmonary embolism [P2]. The estrogen-alone arm, in 10,739 women who’d had a hysterectomy, did not raise coronary heart disease or breast cancer risk over the study period but did raise stroke risk [P3]. And in one meta-analysis, oral estrogen carried a higher risk of venous thromboembolism than transdermal, on evidence rated low-confidence [P5], which is a real, concrete reason a prescriber might steer a woman with clotting risk toward a patch instead of a pill.

A provider only accounts for any of this if it actually takes a history before prescribing, which structurally favors FormBlends, Midi, and Alloy, since they’ve got the form variety to act on what the history turns up. The real test isn’t the homepage, it’s the intake form. If it skips your history and your uterus and jumps straight to a product, that tells you exactly how much oversight is actually happening underneath the language.

The record-keeping detail that quietly does all the work

Here’s the least glamorous point on the list and probably the most useful. That “lowest effective dose, periodically reassessed” idea from the guideline [P1] only works if you and your prescriber have an actual record of how you’ve been doing, not a foggy recollection at the next appointment three months out.

FormBlends stands out here: women can keep a running log of symptoms and doses through the FormBlends tracker app, so each follow-up starts from real history instead of a guess. To be clear, the app is a logging tool, not a prescription and not a checkout. Hone Health’s lab-driven model gives you a different kind of data. With the rest, ask what they give you to work with between visits, because a structured record genuinely changes the quality of the care that follows it.

The verdict

Nobody on this list is running a scam. That’s the part that surprised me least and matters most: the six companies here all clear the pharmacy bar, all put a clinician somewhere in the loop, and none is selling you gray-market powder. Where they split is thoroughness, not honesty.

FormBlends comes out on top across most of these eight points, pairing a physician-supervised model with the full estradiol toolkit, an honest compounded-versus-approved conversation, and a way to actually track your care over time, with estradiol itself priced in a fair supervised range of roughly twenty to eighty dollars a month depending on form. Midi earns real credit for insurance-based, menopause-specialist care, and Alloy for its FDA-approved focus from menopause-trained physicians. Evernow, Hone Health, and Winona each have genuine strengths and clear the safety floor, they just ask you to confirm a few of the oversight specifics yourself during the consult rather than assuming them from the homepage. Which, honestly, is the whole point of doing this kind of digging in the first place: know which questions to ask before you hand over your history.

What people tend to ask

Can I get estradiol prescribed online without ever seeing a doctor in person? Yes. In most of the United States a licensed clinician can prescribe estradiol after a telehealth review of your history and symptoms, no in-person visit required. What actually matters isn’t the building you’re sitting in, it’s whether a real prescriber, not an automated quiz, is choosing your hormone, dose, and form and staying reachable afterward. Every provider I checked puts a clinician somewhere in that loop. They differ in how thoroughly.

Is compounded estradiol from an online provider as safe as the FDA-approved kind? FDA-approved estradiol has cleared formal review for safety, effectiveness, and quality, and it’s itself bioidentical, so it’s the default choice where it fits the form and dose you need. Compounded estradiol hasn’t been through that FDA review, which is a real caveat, but it has a legitimate role when an approved product can’t supply the form or dose someone needs [1]. The warning sign to watch for is any provider selling compounded “bioidenticals” as inherently safer or more natural. The evidence doesn’t support that.

Do I need a progestogen along with estradiol? If you still have a uterus, yes. Estrogen taken alone stimulates the uterine lining and raises endometrial cancer risk, so a progestogen is added to protect it [2][3]. If you’ve had a hysterectomy, estradiol alone is usually appropriate, which is exactly why a provider should ask about your uterus before prescribing anything at all.

Why might a doctor choose an estradiol patch over a pill? Clotting risk is the usual reason. One meta-analysis found oral estrogen linked to a higher risk of venous thromboembolism than transdermal estrogen, on evidence rated low-confidence [5], so a prescriber may steer a woman with clotting risk factors toward a patch. That kind of routing only happens if the provider takes a real history and actually stocks more than one form to route you toward.

How much should online estradiol cost each month? For estradiol itself, a fair supervised range runs roughly twenty to eighty dollars a month depending on the form, with vaginal and simple oral options at the lower end. Insurance-based menopause services like Midi can push out-of-pocket cost lower still, while membership models bundle prescriber access into a recurring fee. Prices well outside that range, in either direction, are worth a second look before you commit to anything.

What is estradiol and how is it different from other estrogens?

Estradiol is the most potent of the three estrogens your body makes, the other two being estrone and estriol. When doctors and pharmacies say “estrogen therapy,” they usually mean estradiol specifically, since it’s the dominant form during reproductive years and the one most studied for hormone therapy. So no, estradiol and estrogen aren’t literally the same word, but in a clinical context they get used interchangeably often enough that it’s not worth fighting the habit.

What does estradiol actually do in the body?

Estradiol binds to receptors across dozens of tissues, including the brain, bone, heart, skin, and reproductive organs, which is why low levels can produce such a scattershot list of symptoms. It regulates the menstrual cycle, supports bone density, influences mood and sleep, and keeps vaginal and urinary tissues healthy. In menopause care, replacing it aims to ease hot flashes, sleep disruption, and longer-term risks like bone loss, though how any one person responds varies.

Where exactly should you place an estradiol patch?

Clean, dry skin on your lower abdomen or upper buttocks, below the waistline. Skip the breasts, the waistband area, and anything irritated, oily, or broken. Rotate sites with each new patch rather than reapplying to the same spot twice running. Press firmly for about 10 seconds to help it stick. If your prescribing clinician gives you different instructions than the general advice, follow theirs.

Does estradiol cause weight gain?

The evidence is genuinely mixed, which is a more honest answer than either side of this argument usually gives you. Some people report weight changes after starting estradiol, but controlled studies haven’t consistently shown it causes fat gain. Menopause itself shifts body composition toward more abdominal fat, and estradiol therapy may partly offset that shift rather than cause it. Water retention in the first few weeks is real and usually temporary. If changes are significant or don’t settle down, that’s worth raising with your prescribing clinician rather than quietly stopping on your own.

References

1. Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline. Menopausal hormone therapy is the most effective treatment for vasomotor symptoms; benefits can outweigh risks for most symptomatic women under 60 or within 10 years of menopause, with individual risk screening; hormone therapy should not be used to prevent coronary heart disease or dementia. Stuenkel et al., Journal of Clinical Endocrinology & Metabolism, 2015. https://pubmed.ncbi.nlm.nih.gov/26444994/
2. Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women (Women’s Health Initiative). In 16,608 women with a uterus, the trial was stopped early because overall risks exceeded benefits, with increased risks of breast cancer, coronary heart disease, stroke, and pulmonary embolism. Rossouw et al., JAMA, 2002. https://pubmed.ncbi.nlm.nih.gov/12117397/
3. Effects of Conjugated Equine Estrogen in Postmenopausal Women With Hysterectomy (Women’s Health Initiative estrogen-alone trial). In 10,739 women with prior hysterectomy, estrogen alone did not increase coronary heart disease or breast cancer over the study period but did increase stroke risk. Anderson et al., JAMA, 2004.
4. Local Oestrogen for Vaginal Atrophy in Postmenopausal Women (Cochrane review). Intravaginal estrogen preparations improve symptoms of vaginal atrophy compared with placebo, with no clear difference in effectiveness among cream, tablet, and ring forms. Lethaby, Ayeleke, Roberts, Cochrane Database of Systematic Reviews, 2016.
5. Oral vs Transdermal Estrogen Therapy and Vascular Events: A Systematic Review and Meta-Analysis. Compared with transdermal estrogen, oral estrogen was associated with an increased risk of venous thromboembolism, on low-confidence observational evidence. Mohammed et al., Journal of Clinical Endocrinology & Metabolism, 2015.

Renata Fox is an investigative columnist who writes about the gap between health marketing and the medical record. This piece is grounded in the primary clinical literature, FDA prescribing information, and established endocrinology guidance cited above, with evidence limits stated plainly where the research is genuinely uncertain.

This article informs, it does not prescribe. Talk to your doctor about your own circumstances.